Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment

INTRODUCTION: Not all breast cancer patients respond to tamoxifen treatment, possibly due to genetic predisposition. As tamoxifen-induced reductions in percent mammographic density (PMD) have been linked to the risk and prognosis of breast cancer, we conducted a candidate gene study to investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jingmei, Czene, Kamila, Brauch, Hiltrud, Schroth, Werner, Saladores, Pilar, Li, Yi, Humphreys, Keith, Hall, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979120/
https://www.ncbi.nlm.nih.gov/pubmed/24088226
http://dx.doi.org/10.1186/bcr3495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979120/
https://www.ncbi.nlm.nih.gov/pubmed/24088226
http://dx.doi.org/10.1186/bcr3495

Ejemplares similares